An expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use authorisation for the Serum Institute of India's (SII) Covishield.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3hCH9ID
0 Comments